Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium release-activated channel regulator 2B (CRACR2B) is a protein-coding gene that encodes a regulator protein involved in store-operated calcium entry (SOCE), an essential biological pathway for calcium influx in non-excitable cells. CRACR2B binds calcium ions and participates in the activation or modulation of CRAC channels, which replenish endoplasmic reticulum calcium stores and are vital for diverse cellular functions, including immune cell activation and gene expression[1][4][5]. Mutations or dysregulation in the SOCE pathway, including its regulators, are linked to disorders such as developmental and epileptic encephalopathies. Unlike the core CRAC channel pore-forming proteins (e.g., Orai1), CRACR2B acts as a regulator and is not itself the channel pore; it is essential for proper Ca2+ signaling and immune responses but has not been established as a direct pharmacological target to date[1].
Store-operated calcium channel modulation (modifies SOCE pathway via regulation of CRAC channel activation) Not a primary drug target itself, but acts upstream/in concert with CRAC channel components
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium release-activated channel regulator 2B (CRACR2B).